Trial
NCT03738878
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Vanderbilt University Medical Center
Collaborators
—
Condition
Hypertension
Intervention
Valsartan
Why stopped
An alternative study was developed to replace this study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-03